Mia's Feed
Medical News & Research

Innovative Smart Insole Enhances Mobility for Individuals with Gait Challenges

Innovative Smart Insole Enhances Mobility for Individuals with Gait Challenges

Share this article

A new smart insole embedded with flexible sensors offers a low-cost solution to improve balance and prevent falls in individuals with walking difficulties, potentially transforming gait monitoring and mobility support.

2 min read

Maintaining balance during walking often goes unnoticed until difficulties arise, especially in individuals affected by conditions like stroke or Parkinson’s disease. Gait impairments not only slow down movement but also significantly increase the risk of falls, posing serious safety concerns. While traditional solutions like physical therapy are effective, they tend to be time-consuming and costly.

Recent developments have introduced a promising wearable technology designed to improve mobility. Researchers at Georgia Tech have created a smart insole embedded with over 170 ultra-thin, flexible sensors that measure foot pressure—a crucial indicator of balance and gait stability. This device can be inserted into any shoe and utilizes screen-printing techniques to produce affordable, scalable sensors. The pressure data collected aims to predict and prevent falls by identifying imbalance patterns.

The innovative sensor array and electronically conductive nanomaterials were detailed in the paper "Flexible Smart Insole and Plantar Pressure Monitoring Using Screen-Printed Nanomaterials and Piezoresistive Sensors," published in the August edition of ACS Applied Materials & Interfaces. This research emphasizes the benefits of screen-printing for medical device manufacturing, highlighting its low-cost and scalability advantages.

Designed with user comfort and ease of integration in mind, the device employs Bluetooth connectivity, allowing smartphones to gather real-time data and interface with existing health monitoring systems. Its compact and lightweight form factor makes it suitable for diverse applications—from assisting stroke and Parkinson’s patients and the elderly to supporting athletes analyzing their performance.

The team aims to keep the manufacturing cost below $100, making this device accessible for widespread use. Initial testing on healthy subjects shows promising potential, with plans to expand trials to diverse populations with gait impairments. The ultimate goal is to bring this technology into clinical and everyday settings, providing immediate and practical support for those with mobility challenges.

This smart insoles’ wireless and real-time feedback capabilities could revolutionize gait analysis and fall prevention, bridging the gap between advanced laboratory prototypes and everyday accessible medical devices. The development underscores an important step toward affordable, portable, and intelligent mobility assistance.

For more details, see the full study: ACS Applied Materials & Interfaces, 2025. Source: Georgia Institute of Technology.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Safety-Net Hospitals Bear the Highest Costs from Gun-Related Injuries, Study Shows

A new study highlights how safety-net hospitals in the US bear the brunt of financial costs associated with gun injuries, with treatment costs reaching over $7.7 billion between 2016 and 2021, emphasizing the need for increased support and prevention efforts.

Addressing Transport and Mobility Challenges in Older Adults

Exploring solutions to overcome transportation and mobility challenges faced by older adults to promote independence, safety, and well-being in aging populations.

Herpes Virus Engineered to Fight Advanced Melanoma Shows Promising Results

A groundbreaking study demonstrates that a genetically engineered herpes simplex virus shows promising results in treating advanced melanoma, especially those resistant to immunotherapy, offering new hope for patients worldwide.

Biweekly TAS-102 Dosing Reduces Toxicity While Maintaining Effectiveness in Colorectal Cancer Treatment

A new study shows that biweekly dosing of TAS-102 can effectively treat metastatic colorectal cancer with fewer side effects, improving patient outcomes and quality of life.